Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin

July 28, 2025 updated by: TCI Co., Ltd.
Evaluate the effects of blood peach extract drink and rose apple extract drink on enhancing hemoglobin and iron levels, and improving skin health.

Study Overview

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taichung City, Taiwan, 406040
        • China Medical University of Department of Cosmeceutics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adult females aged 20 to 65;
  • Preferably those with pale complexion or signs of iron deficiency anemia.

Exclusion Criteria:

  • Currently undergoing or having undergone any medical beauty treatments within the past month (including skincare, laser treatments, chemical peel, injections, or cosmetic surgery);
  • Outdoor workers (exposed to sunlight for more than 5 hours daily);
  • Pregnant, breastfeeding, or planning to become pregnant during the trial (self-reported);
  • Individuals with heart, liver, kidney, endocrine, or other significant organic diseases (self-reported);
  • Individuals who have undergone major surgery (according to medical history);
  • Long-term medication users;
  • Individuals with mental health disorders;
  • Those who are already regularly taking iron supplements;
  • Faculty or staff members who are currently enrolled in the principal investigator's courses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Take one bottle of the product every morning on an empty stomach
Experimental: Blood Peach Extract
Take one bottle of the product every morning on an empty stomach
Experimental: Rose Apple Extract
Take one bottle of the product every morning on an empty stomach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the volume of skin wrinkles
Time Frame: Volume change from Baseline skin wrinkles at 8 weeks
IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units
Volume change from Baseline skin wrinkles at 8 weeks
the roughness of skin texture
Time Frame: Rating skin roughness from Baseline skin texture at 8 weeks
IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units
Rating skin roughness from Baseline skin texture at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the change of skin elasticity
Time Frame: Change from Baseline skin elasticity at 8 weeks
Cutometer® was utilized to measure skin elasticity. Units: arbitrary units
Change from Baseline skin elasticity at 8 weeks
the change of skin collagen density
Time Frame: Change from Baseline skin collagen density at 8 weeks
Dermalab® Combo was utilized to measure skin collagen density. Units: arbitrary units
Change from Baseline skin collagen density at 8 weeks
the change of skin pores
Time Frame: Change from Baseline skin pores at 8 weeks
IRV full-face skin analyzer was utilized to measure skin pores. Units: arbitrary units
Change from Baseline skin pores at 8 weeks
the change of skin tone
Time Frame: Change from Baseline skin tone at 8 weeks
IRV full-face skin analyzer was utilized to measure skin tone. Units: arbitrary units
Change from Baseline skin tone at 8 weeks
the change of skin hydration
Time Frame: Change from Baseline skin hydration at 8 weeks
Corneometer® was utilized to measure skin hydration. Units: arbitrary units
Change from Baseline skin hydration at 8 weeks
the change of skin melanin/erythema index
Time Frame: Change from Baseline skin melanin/erythema index at 8 weeks
Mexameter® was utilized to measure skin melanin/erythema index. Units: arbitrary units
Change from Baseline skin melanin/erythema index at 8 weeks
the change of skin redness
Time Frame: Change from Baseline skin redness at 8 weeks
Colorimeter was utilized to measure skin redness. Units: arbitrary units
Change from Baseline skin redness at 8 weeks
the change of lip redness
Time Frame: Change from Baseline lip redness at 8 weeks
Antera 3D® was utilized to measure lip redness. Units: arbitrary units
Change from Baseline lip redness at 8 weeks
the change of Red Blood Cells (RBC) Count of blood
Time Frame: Change from Baseline RBC count at 8 weeks
venous blood was sampled to measure RBC count
Change from Baseline RBC count at 8 weeks
the change of hemoglobin level of blood
Time Frame: Change from Baseline hemoglobin level at 8 weeks
venous blood was sampled to measure hemoglobin level
Change from Baseline hemoglobin level at 8 weeks
the change of mean corpuscular volume (M.C.V) level of blood
Time Frame: Change from Baseline M.C.V level at 8 weeks
venous blood was sampled to measure M.C.V level
Change from Baseline M.C.V level at 8 weeks
the change of mean corpuscular hemoglobin concentration (M.C.H.C) level of blood
Time Frame: Change from Baseline M.C.H.C level at 8 weeks
venous blood was sampled to measure M.C.H.C level
Change from Baseline M.C.H.C level at 8 weeks
the change of ferrous level of blood
Time Frame: Change from Baseline ferrous level at 8 weeks
venous blood was sampled to measure ferrous level
Change from Baseline ferrous level at 8 weeks
the change of ferritin level of blood
Time Frame: Change from Baseline ferritin level at 8 weeks
venous blood was sampled to measure ferritin level
Change from Baseline ferritin level at 8 weeks
the change of Total Iron Binding Capacity (TIBC) level of blood
Time Frame: Change from Baseline TIBC level at 8 weeks
venous blood was sampled to measure TIBC level
Change from Baseline TIBC level at 8 weeks
the change of unsaturated iron-binding capacity (UIBC) level of blood
Time Frame: Change from Baseline UIBC level at 8 weeks
venous blood was sampled to measure UIBC level
Change from Baseline UIBC level at 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
the change of liver function biomarkers (AST, ALT) of blood
Time Frame: change from Baseline liver function biomarkers at 8 weeks
venous blood was sampled to measure liver function biomarkers
change from Baseline liver function biomarkers at 8 weeks
the change of renal function biomarkers (creatinine, BUN) of blood
Time Frame: change from Baseline renal function biomarkers at 8 weeks
venous blood was sampled to measure renal function biomarkers
change from Baseline renal function biomarkers at 8 weeks
the change of fasting glucose level of blood
Time Frame: change from Baseline fasting glucose level at 8 weeks
venous blood was sampled to measure fasting glucose level
change from Baseline fasting glucose level at 8 weeks
the change of Advanced glycation end products (AGEs) level of blood
Time Frame: change from Baseline AGEs level at 8 weeks
venous blood was sampled to measure AGEs level
change from Baseline AGEs level at 8 weeks
The change of self-assessment skin and metabolic circulation condition
Time Frame: Change from Baseline skin and metabolic circulation condition at 8 weeks
A self-assessment questionnaire was collected to evaluate skin and metabolic circulation condition. As for the evalutation of skin condition, the higher score the better; As for evaluation of metabolic circulation condition, the higher score the worse.
Change from Baseline skin and metabolic circulation condition at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hsiu-Mei Chiang, China Medical University of Department of Cosmeceutics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2025

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

July 15, 2025

Study Registration Dates

First Submitted

February 25, 2025

First Submitted That Met QC Criteria

February 25, 2025

First Posted (Actual)

March 3, 2025

Study Record Updates

Last Update Posted (Actual)

July 30, 2025

Last Update Submitted That Met QC Criteria

July 28, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CMUH114-REC3-005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dermatology

Clinical Trials on Placebo Drink

Subscribe